1. Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors

    Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors

    (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the election of Anne Klibanski, M.D., and Stephanie Okey, M.S., to its board of directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Albireo has reached a new stage in its growth, and I am delighted to welcome two very high-caliber leaders to our board.
    2. On behalf of the board and leadership team, I'd like to thank Heather and Julia for their years of service and counsel.
  3. Topics Mentioned

  4. Authors